Results 261 to 270 of about 5,395,673 (305)
Some of the next articles are maybe not open access.
Combined modality therapy for esophageal cancer
Seminars in Oncology, 2003Treatment approaches for esophageal cancer include primary treatment (surgical or nonsurgical) or adjuvant treatment (preoperative or postoperative). Primary treatments include surgery alone, radiation therapy alone, and radiation therapy plus chemotherapy (combined modality therapy).
openaire +2 more sources
Combination modality cancer therapy
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988Coordination compounds for use in therapy, the compounds having the general empirical formula [Rhm Xx Yy ]a in which m is the oxidation state of Rh, X is at least one anionic ligand, Y is at least one neutral ligand, with the proviso that at least one of X and Y is a nitrogen donor ligand, x is an integer from 1 to 6, y is an integer from 1 to 5 or may
Donald H Picker, Paul C Hydes
openaire +1 more source
Thyroid lymphoma. The case for combined modality therapy
Cancer, 1994Radiation therapy with or without surgery is generally considered standard treatment for lymphoma of the thyroid. Because of the small number of cases, the role of chemotherapy or combined modality treatment is difficult to determine.The published literature was analyzed, supplemented by a series from Yale, for the incidence of local and distant ...
R, Doria, J F, Jekel, D L, Cooper
openaire +2 more sources
Combined modality therapy of acute lymphocytic leukemia
Cancer, 1975The progressive improvement in the prognosis of acute lymphocytic leukemia has been a result of two major developments: 1) the more efficient use of chemotherapeutic agents, particularly the use of combinations of agents and the discovery that agents effective at one stage of disease may be inappropriate at another stage, and 2) the prevention with ...
J V, Simone +4 more
openaire +2 more sources
Taxanes in combined modality therapy for solid tumors
Critical Reviews in Oncology/Hematology, 2001The taxanes, paclitaxel and docetaxel, are novel antimitotic agents that are under extensive investigation in clinical trials. Both taxanes have demonstrated significant activity against many solid tumors as single agents and in combination with other chemotherapeutic agents.
openaire +3 more sources
Chemotherapy and Combined-Modality Therapy for Esophageal Cancer
Chest, 1995Treatment of esophageal carcinoma with radiation alone or surgery alone has yielded unsatisfactory cure rates and has not had a major impact on survival. The failure to cure or prolong survival of patients with esophageal cancer is because of our inability to eradicate residual disease at the primary site and to early systemic dissemination of disease.
D P, Kelsen, D H, Ilson
openaire +2 more sources
Taxanes in Combined Modality Therapy
2003The taxanes are a relatively new group of plant-derived chemotherapeutic agents that have been studied quite extensively in both preclinical studies and in clinical trials. This group of drugs, which includes paclitaxel (Taxol) and docetaxel (Taxotere), act as mitotic spindle inhibitors through their promotion of microtubule assembly and retardation of
Robert M. MacRae, Hak Choy
openaire +1 more source
Combined modality therapy for rectal and colon cancer
Seminars in Oncology, 2003Combined modality therapy (CMT) with radiation therapy and chemotherapy plays an important role in the management of rectal cancer. Postoperatively, pelvic irradiation and 5-fluorouracil-based chemotherapy have been used to improve local control and survival for high-risk patients after local excision, as well as for patients undergoing ...
Ashish K, Chawla +3 more
openaire +2 more sources
Preoperative combined modality therapy for pancreatic cancer
World Journal of Surgery, 1995AbstractCombined modality therapy can be administered prior to surgical resection for patients with operable pancreatic cancer. One important criteria used to select patients for this treatment sequence is the absence of arterial vascular encasement by tumor on thinâsection CT scanning; the absence of peritoneal seeding on surgical staging or ...
T A, Rich, D B, Evans
openaire +2 more sources
Combined modality therapy in the treatment of gynecologic malignancies
Seminars in Oncology, 2003During the last several years, combined modality therapy has become increasingly important in the treatment of several malignancies. This trend holds true in the treatment of the gynecologic malignancies. In this review we examine the evolving role of combined modality therapy in the treatment of patients with cervical, vulvar, endometrial, and ovarian
Mark A, Engleman, William, Small
openaire +2 more sources